Results 151 to 160 of about 635,806 (258)
Institutional and policy networks in disaster management in the Horn of Africa: insights from Kenya. [PDF]
Mohamed T.
europepmc +1 more source
ABSTRACT Shell middens in Gippsland along the eastern half of Victoria's coastline have usually been characterised as small, short‐duration camp sites with relatively low shell densities and low taxonomic diversity. Here we present new excavation results from a dense, high‐diversity site at Red Bluff near the eastern end of GunaiKurnai Country, a ...
Patrick Faulkner +17 more
wiley +1 more source
Challenges Faced by Nurses in Disaster Management in Palestine: A Systematic Review. [PDF]
Qtait M +7 more
europepmc +1 more source
Objective The multinational, phase 3, double‐blind, placebo‐controlled TULIP‐SC trial evaluated the efficacy and safety of subcutaneous anifrolumab in adults who have moderate to severe systemic lupus erythematosus (SLE) activity, despite receiving standard therapy. Methods Adults with SLE received subcutaneous anifrolumab 120 mg or placebo once weekly
Susan Manzi +12 more
wiley +1 more source
Evaluating the effectiveness of the Jennings disaster management model on nursing students' knowledge and self-efficacy. [PDF]
Ramadan SM, Mohamed M, Abo-Elmaty G.
europepmc +1 more source
G‐CSF for Mobilizing CD34+ Cells in Individuals With SCD: A Word of Caution
American Journal of Hematology, EarlyView.
Akshay Sharma +17 more
wiley +1 more source
Objective Evaluate the efficacy and safety of guselkumab, an interleukin‐23p19‐subunit inhibitor, in participants with active psoriatic arthritis (PsA) and inadequate response (inadequate efficacy and/or intolerance) to one prior tumor necrosis factor inhibitor (TNFi‐IR).
Alexis Ogdie +12 more
wiley +1 more source
Structured AI decision-making in disaster management. [PDF]
Dcruz JG +3 more
europepmc +1 more source
Coverage generosity of novel anti‐rheumatic drugs in Medicare Advantage and stand‐alone Part D plans
Objective To examine coverage of self‐administered disease‐modifying anti‐rheumatic drugs (DMARDs) in Medicare Part D. Methods Using 2022‐2026 Part D formulary data, we assessed coverage of the following DMARD classes that treat relapsed rheumatoid arthritis (RA): tumor necrosis factor (TNF) inhibitors, T‐cell co‐stimulatory modulator, Interleukin‐6 ...
Youngmin Kwon +2 more
wiley +1 more source
Disaster management knowledge, education and training among Saudi paramedics a scoping review. [PDF]
Alqahtani MA, Toloo GS.
europepmc +1 more source

